Market Overview:
The global positron emission tomography market is expected to exhibit a CAGR of 6.1% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Positron emission tomography (PET) is a combination of nuclear medicine and biochemical analysis that is utilized for measuring the metabolic activity of cells. It functions by administering a small amount of radioactive glucose (sugar) into the vein of the patient through an intravenous (IV) line. A scanner and computer then generate detailed pictures of areas containing the glucose, which helps in evaluating the functions of organs and tissues effectively. Consequently, PET is utilized as an effective solution in the early detection of cancer, heart diseases and brain disorders as compared to other imaging techniques. Nowadays, it is used along with computed tomography (CT) and magnetic resonance imaging (MRI) scans to assist in the diagnosis of lung cancer, epilepsy, Alzheimer's disease and coronary artery disease.
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
At present, the market is experiencing growth on account of the sudden outbreak of the coronavirus disease (COVID-19). PET assists in the study of the pathogenesis of infectious diseases and the development and assessment of novel therapeutics. Other than this, the growing number of people who have cancer, neurological disorders and cardiovascular diseases, represent another key factor impelling the global PET market growth. Moreover, the increasing adoption of hybrid imaging techniques, along with the reimbursements provided by governments of several countries, is creating opportunities for PET scanner manufacturers. Furthermore, the clinical trials, such as radiotherapy planning based on fluoro-deoxyglucose positron emission tomography (FDG-PET), are expected to drive the market significantly in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global positron emission tomography (PET) market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, detector type, application and end-user.
Breakup by Product Type:
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Full Ring PET Scanners
- Partial Ring PET Scanners
Breakup by Detector Type:
- Bismuth Germanium Oxide (BGO)
- Lutetium Oxyorthosilicate (LSO)
- Lutetium Fine Silicate (LFS)
- Lutetium Yttrium Orthosilicate (LYO)
- Gadolinium Oxyorthosilicate (GSO)
Breakup by Application:
- Cardiology
- Neurology
- Oncology
- Others
Breakup by End-User:
- Hospitals and Clinics
- Diagnostic Centers
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Agfa Healthcare (Dedalus Group), GE Healthcare, Koninklijke Philips NV, Neusoft Medical Systems, Positron Corporation, Oncovision (Bruker), Mediso Medical Imaging Systems Ltd., Siemens Healthineers AG, Segami Corporation, Hitachi Ltd., etc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2021 |
Historical Period |
2016-2021 |
Forecast Period |
2022-2027 |
Units |
US$ Million |
Segment Coverage |
Product Type, Detector Type, Application, End-User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Agfa Healthcare (Dedalus Group), GE Healthcare, Koninklijke Philips NV, Neusoft Medical Systems, Positron Corporation, Oncovision (Bruker), Mediso Medical Imaging Systems Ltd., Siemens Healthineers AG, Segami Corporation and Hitachi Ltd. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global positron emission tomography (PET) market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global positron emission tomography market?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the detector type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global positron emission tomography market and who are the key players?
- What is the degree of competition in the industry?